International Technology Forum on in vitro-Diagnostics and Bioanalysis 2014

12.06.2014 - 13.06.2014

International Technology Forum on in vitro-Diagnostics and Bioanalysis 2014

„Perspectives and Challenges of New Biomarker Development”

June 12th – 13th, 2014

Official Technology Forum 2014 website and registration:

Join the annual meeting for in vitro-Diagnostics and find out more about the latest trends in technology, clinics and industrial research for in vitro-Diagnostics!

  • Scientific lectures: presenting the latest trends in the development of diagnostics.
  • Partnering Event  with pre-scheduled one-to-one meetings for companies and research institutes from Germany and abroad.
  • Company Presentations by international innovative diagnostics companies.
  • Industrial Exhibition: showcasing products, services and technologies.
  • Accompanied by a Guided Science Tour to Labor Berlin, the biggest clinical laboratory in Europe. 


June, 12th     

15.00  Guided Science Tour

18.00  Welcome Reception

            Welcome Address

            Roland Hetzer, Deutsches Herzzentrum Berlin

            Kai Bindseil, Clustermanager Gesundheitswirtschaft Berlin-Brandenburg

            Welcome Lecture

            Biomarker Strategy at Sanofi Aventis
            Kathrin Heermeier, Sanofi Aventis Deutschland GmbH, Frankfurt am
            Main, Germany

            Diagnostics and Stratified Medicine in UK: Changing paradigms in clinics
            and patient treatment
            Munir Pirmohamed, University of Liverpool, Liverpool, United Kingdom


June 13th      

09.00  Welcome Address           

            Rudolf Tauber, Charité - Universitätsmedizin Berlin

            Simon MacDonald, British Embassy, Berlin

09.15  Personalized healthcare 3.0: Vision & implications for in vitro diagnostics
            Achim Plum, Corporate Technology, Siemens AG, Vienna, Austria

09.40  Biomarker and personalized medicine – From candidate to clinical

            The clinical point of view
            Joachim Thiery, Universitätsklinikum Leipzig, Leipzig, Germany

            The industrial point of view
            Guido Schütte, Roche

10.20  Coffee

            Session I: Biomarker and Clinical Research

10.50  Current needs for the diagnosis of neurodegenerative disorders: Can in
            vitro tools solve the problem?
            Etienne Hirsch, Institut Thématique Multi-organismes Neurosciences,
            Sciences cognitives, Neurologie, Psychiatrie, Paris, France

11.25  Towards personalized nutrition – What does it mean for diagnostic
            demands in the future?
            Hannelore Daniel, Technische Universität München, München, Germany

11.50  Non-invasive analysis of cancer genome with circulating tumour DNA
            Florent Mouliere, University of Cambridge, Cambridge, United Kingdom

12.15  The route to diagnostics of relevance in developing countries
            Mark Perkins, Foundation for Innovative New Diagnostics, Geneva,

12.40   Lunch

            Session II: Technology Development

13.40  Big data, data protection and stratified medicine – The British point of
            N. N., United Kingdom

14.05  Circulating miRNAs and lncRNAs as diagnostic tools in various diseases
            Thomas Thum, Medizinische Hochschule Hannover, Hannover, Germany

13.30  Microfluidic flow cytometers for blood cell differentiation
            Jörg Neukammer, Physikalisch-Technische Bundesanstalt, Berlin,

14.50  T(h)eraDiagnostics platform and perspectives for future development of
            Frank Bier, Fraunhofer IBMT, Potsdam, Germany

14.45  Will glycane based assays become relevant for tumor diagnostics?
            Véronique Blanchard, Charité – Universitätsmedizin Berlin, Berlin,

15.30  Coffee

            Session III: Industrial Development – Medical Application

16.00  Metabolites in heart disease studies
            Frank Beutner,Herzzentrum Leipzig Leipzig, Leipzig, Germany

16.20  Early diagnosis of heart failure - from discovery to a targeted assay
            Tim Boelke, Metanomics Health, Berlin, Germany

16.40  Automatic Analysis of DNA Double Strand Breaks via gH2AX-Foci – A
            Potential Marker for Individual Radio- and Chemosensitivity
            Christina Fritz, Medipan GmbH, Dahlewitz, Germany

16.50  N.N.

17.00  Funding opportunities for Biomarker-research in Horizon 2020
            Wolfgang Korek, Berlin Partner für Wirtschaft und Technologie GmbH,
            Berlin, Germany

17.10  End of Programme

17.30  Guided City Tour
            Join us for a walk through the historical heart of Berlin lead by
            professional guides just after the Technology Forum. The tour will end in
            a relaxed dinner. Meeting point: Friedrichstraße

            The Guided tour is free of charge, dinner is to be paid individually,
            details will be announced.


<media 12513>Download Flyer (pdf)</media>

Participation in the Technology Forum (lectures, industrial exhibition) is free of charge.

The fee for the partnering event amounts € 50,00 (VAT not included).

Please note that the Welcome Reception on June 12th, will take place at the Deutsches Herzzentrum Berlin. Due to limited space, participation is only possible on special invitation.



Charité – Universitätsmedizin Berlin
Campus Virchow-Klinikum, Berlin, GER
Forum 3 (<media 12512 - - "TEXT, CVK-3D-Lehrgebaeudeplan 01, CVK-3D-Lehrgebaeudeplan_01.pdf, 353 KB">site plan</media>)
Augustenburger Platz 1
13353 Berlin

<media 12277 - - "TEXT, CVK Forum 3 Anfahrt Englisch 2014, CVK_Forum_3_Anfahrt_Englisch_2014.pdf, 214 KB">Directions</media> (pdf)

Please register for the event here


Berlin Partner für Wirtschaft und Technologie GmbH • Zentrum für Molekulare Diagnostik und Bioanalytik (ZMDB) • Dr. Günter Peine •  •



Bitte beachten Sie, dass auf der Veranstaltung Fotos gemacht werden. Diese werden für unsere Öffentlichkeitsarbeit verwendet.

Please notice that for PR purposes photos are being taken during our events.